Latest news
HIMS Stock Slides Premarket: Rival Telehealth Firm Ro Launches Aggressive Price Cuts In GLP-1 Subscription Fight - StocktwitsStocktwits · Sat, 08 Aug 2026 08:12:26 GMTHIMS Stock Eyes 4-Week Losing Streak: Legal Woes Fuel ‘Very High’ Uncertainty As Analyst Sticks To ‘No Moat’ Call - StocktwitsStocktwits · Sat, 08 Aug 2026 05:39:27 GMTHIMS Stock Heads For Weekly Loss — But Ex-Netflix CFO Is Buying The Dip Despite BofA’s GLP-1 Warning - StocktwitsStocktwits · Sat, 08 Aug 2026 05:19:17 GMTHims & Hers Adds Lilly GLP-1 Treatments To Lineup – CEO Compares It To Netflix’s Early Days - StocktwitsStocktwits · Fri, 07 Aug 2026 20:34:38 GMTNasdaq, S&P 500 Futures Rise With ‘War Trade’ Unwinding: Why NFLX, WSHP, PBM, HIMS, NVDA Are Keeping Traders Engaged Today - StocktwitsStocktwits · Fri, 07 Aug 2026 17:33:25 GMTHIMS Stock Eyes 2-Week Green Streak: Analyst Sees Nearly 20% Upside On Multi-Year Opportunity In Peptides - StocktwitsStocktwits · Fri, 07 Aug 2026 10:37:39 GMTHIMS Stock Tumbles As Branded GLP-1 Pivot Triggers Margin Hit And One-Time Charges - StocktwitsStocktwits · Fri, 07 Aug 2026 06:57:57 GMTHIMS Stock Eyes Breakout Week: Eight New Partners Fuel Push To Build An All-In-One Health Platform - StocktwitsStocktwits · Fri, 07 Aug 2026 06:09:32 GMT